maprotiline has been researched along with Cognition Disorders in 3 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stapert, WG | 1 |
| Brock-Utne, JG | 1 |
| Goodwin, NM | 1 |
| Hicks, JC | 1 |
| Sandyk, R | 1 |
3 other studies available for maprotiline and Cognition Disorders
| Article | Year |
|---|---|
[The child who is suddenly confused and hallucinating].
Topics: Anthracenes; Child; Cognition Disorders; Confusion; Drug Synergism; Hallucinations; Humans; Imiprami | 1983 |
Acute confusional states and depression treated with maprotiline mesylate. Report of 4 patients successfully treated in an intensive care unit.
Topics: Anthracenes; Cognition Disorders; Confusion; Critical Care; Depression; Humans; Male; Maprotiline; M | 1979 |
Maprotiline for disordered cognitive function in Parkinson's disease.
Topics: Anthracenes; Cognition Disorders; Humans; Male; Maprotiline; Middle Aged; Parkinson Disease | 1986 |